NCT07446322Phase 2Recruiting

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

Study sponsor: Oncolytics Biotech

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-08-30Estimated
Enrollment · participants60Estimated
Source updated2026-11-05Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source